IsletRegen

IsletRegen is a Charlottesville, Virginia biotechnology company co-founded in September 2021 that is developing a regenerative approach to treating autoimmune diseases, including type 1 and type 2 diabetes. The company is pursuing natural replacement therapy targeting insulin-producing islet cells and is associated with University of Virginia researchers.